Our Team
Professor Ross Baker
MBBS BMedSc FRACP FACP FRCPA
Professor Ross Baker is currently:
His major interest is the translation of new scientific discoveries into clinical haematology practice.
As Principal Investigator in, more than 95 large international phase II and III clinical trials, he has actively led and participated in clinical research in venous thrombosis, leukaemia, lymphoma, myeloma, thrombocytopenia Von Willebrand disease and haemophilia. Since 1992 he has authored over 100 papers in peer reviewed journals and has been a regularly invited speaker at national and international haematology and medical meetings. He is a founding director and secretary of the Australasian Society for Thrombosis and Haemostasis (ASTH) and scientific advisor to the World Health Organisation on DVT in 2001.
His professional memberships include the Haematology Society of Australia and New Zealand, Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), Australian Haemophilia Centre Directors Organisation (AHCDO), International Society Thrombosis and Haemostasis, American Society of Haematology, Australian Leukaemia and Lymphoma Study Group, and the Chronic Lymphocytic Leukaemia Australian Research Consortium (CLLARC),
He is also past President of the Australasian Society Thrombosis Haemostasis from 1997 to 2001, Haematology Advisory member of the Royal Australasian College of Pathologists 1998 to 2003 and Councillor for the Haematology Society of Australia and New Zealand from 1992 to 1999.
He currently is an Australian Councillor on the Asian Pacific Thrombosis and Haemostasis Society (ASPTH) and Chairman of the Australasian Society of Thrombosis Haemostasis (ASTH) new oral anticoagulant Reversal and Event Collaborative (ARES), Asian Pacific Thrombosis and Thrombocytopenia Network (APTIN), the Perth Blood Institute and the executive committee for the International Society of Thrombosis and Haemostasis Meeting in Melbourne 2019.
He has extensive clinical and laboratory experience in a wide range of haematological disorders and has been a consultant in haematology for over 20 years.
MBBS BMedSc FRACP FACP FRCPA
Professor Ross Baker is currently:
- Senior Consultant Haematologist - Hollywood Hospital
- Director, WA Centre for Thrombosis and Haemostasis, Murdoch University
- Director, Haemophilia Treatment Centre – Hollywood Hospital
- Chairman, Perth Blood Institute
His major interest is the translation of new scientific discoveries into clinical haematology practice.
As Principal Investigator in, more than 95 large international phase II and III clinical trials, he has actively led and participated in clinical research in venous thrombosis, leukaemia, lymphoma, myeloma, thrombocytopenia Von Willebrand disease and haemophilia. Since 1992 he has authored over 100 papers in peer reviewed journals and has been a regularly invited speaker at national and international haematology and medical meetings. He is a founding director and secretary of the Australasian Society for Thrombosis and Haemostasis (ASTH) and scientific advisor to the World Health Organisation on DVT in 2001.
His professional memberships include the Haematology Society of Australia and New Zealand, Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), Australian Haemophilia Centre Directors Organisation (AHCDO), International Society Thrombosis and Haemostasis, American Society of Haematology, Australian Leukaemia and Lymphoma Study Group, and the Chronic Lymphocytic Leukaemia Australian Research Consortium (CLLARC),
He is also past President of the Australasian Society Thrombosis Haemostasis from 1997 to 2001, Haematology Advisory member of the Royal Australasian College of Pathologists 1998 to 2003 and Councillor for the Haematology Society of Australia and New Zealand from 1992 to 1999.
He currently is an Australian Councillor on the Asian Pacific Thrombosis and Haemostasis Society (ASPTH) and Chairman of the Australasian Society of Thrombosis Haemostasis (ASTH) new oral anticoagulant Reversal and Event Collaborative (ARES), Asian Pacific Thrombosis and Thrombocytopenia Network (APTIN), the Perth Blood Institute and the executive committee for the International Society of Thrombosis and Haemostasis Meeting in Melbourne 2019.
He has extensive clinical and laboratory experience in a wide range of haematological disorders and has been a consultant in haematology for over 20 years.
Dr Peter Tan
MBBS (Hons) FRACP FRCPA
Clinical Trials Director, Consultant Haematologist
Dr Peter Tan is a consultant haematologist with a particular research interest in haematological malignancies, including acute myeloid leukaemia. Dr Tan is the Director of the Clinical Trials Unit at Perth Blood Institute, where he is the principal or co-investigator on numerous clinical trials. He is also an investigator with the Australasian Leukaemia & Lymphoma Group, where he is the co-principal investigator for the study entitled ‘A strategy of high-dose lenalidomide in combination with epigenetic therapies for relapsed and refractory AML (ALLG AML M17)’.
MBBS (Hons) FRACP FRCPA
Clinical Trials Director, Consultant Haematologist
Dr Peter Tan is a consultant haematologist with a particular research interest in haematological malignancies, including acute myeloid leukaemia. Dr Tan is the Director of the Clinical Trials Unit at Perth Blood Institute, where he is the principal or co-investigator on numerous clinical trials. He is also an investigator with the Australasian Leukaemia & Lymphoma Group, where he is the co-principal investigator for the study entitled ‘A strategy of high-dose lenalidomide in combination with epigenetic therapies for relapsed and refractory AML (ALLG AML M17)’.
Scott McGregor
BPharm (Hons) PGradDipPharm MSHP
Executive Officer, General Manager - Clinical Research
Scott McGregor is a registered pharmacist with extensive experience in clinical trials and oncology pharmacy services. Scott is the Executive Officer and General Manager of Clinical Research at the Perth Blood Institute. Scott is also a consultant haematology pharmacist at Perth Blood Institute and Haematology West.
BPharm (Hons) PGradDipPharm MSHP
Executive Officer, General Manager - Clinical Research
Scott McGregor is a registered pharmacist with extensive experience in clinical trials and oncology pharmacy services. Scott is the Executive Officer and General Manager of Clinical Research at the Perth Blood Institute. Scott is also a consultant haematology pharmacist at Perth Blood Institute and Haematology West.
Adriana Filippou
Public Relations & Communications |
Julie Robinson
Clinical Trials Unit Manager |
Megan Margaria
Senior Clinical Trial Coordinator/Nurse |
Shilpa Rakesh
Research Resident Medical Practitioner |
Neelam Samnakay
Phlebotomist, Western Diagnostic Pathology |
Vanessa Dumouchel
Clinical Trials Coordinator /Start-up Specialist |
Jacey (JiSeon) Jeong
Clinical Trials Assistant/Coordinator |
Sarah Murray
Clinical Trials Nurse |
|
|
|
|